Welcome to the next Oslo University Hospital research seminar entitled "Immunotherapy for Cancer".
Time: Tuesday, April 25th, 2017, at 10:00-15:45.
Place: Store Auditorium, Rikshospitalet, Sognsvannsveien 20, Oslo.
Note that there is a limited number of seats. Please sign up at:
Replication forks must be stabilized in order to avoid DNA breakage and recombination. In a study recently published in Nucleic Acids Research entitled “SeqA structures behind Escherichia coli replication forks affect replication elongation and restart mechanisms“ researchers in the Skarstad group show that double strand breaks are generated in the absence of fork-trailing SeqA structures and that cells then have lost the ability to perform direct (RecA-independent) restart of replication forks. The two first authors are Ida Benedikte Pedersen and Emily Helgesen (photo).
The American Association for Cancer Research (AACR) - Women in Cancer Research (WICR) Charlotte Friend Memorial Lectureship was established in 1998 in honour of renowned virologist and discoverer of the Friend virus, Dr. Charlotte Friend. The WICR Friend Lectureship is presented to an outstanding scientist who has made meritorious contributions to the field of cancer research and who has, through leadership or by example, furthered the advancement of women in science.
Anne-Lise Børresen-Dale, professor emerita at the Department of Cancer Genetics at the Institute for Cancer Research, OUH, has been chosen as the 20th Annual Award Recipient. Her award lecture will be held on April 3rd in the Washington Convention Center.
The CCB seminar Friday March 31st will be held by Pierre Leopold, PhD, Group Leader at the Institut de Biologie Valrose, and Research Director for the National Institute of Health and Medical Research (INSERM), University of Nice.
Title of his talk: Growth coordination during development
Time and place: Friday March 31st at 12:00 PM - 01:00 PM in Seminar room 1 in the Research Building, Institute for Cancer Research, Montebello.
“Centre for Cancer Cell Reprogramming”, affiliated with the Institute of Clinical Medicine at University of Oslo, has been funded by the Research Council of Norway as a new Centre of Excellence.